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Results 
Conclusion Methods 
 
Background 
  
• Acute rheumatic heart disease 
(ARHD) is a serious manifestation 
of acute rheumatic fever (ARF) and 
can result in long-term cardiac 
complications.  
• Literature suggests that the 
incidence of ARF is declining in the 
United States (US).  
• However, the secular variation of 
ARHD has not been investigated in 
the United States. 
• Nationwide Inpatient Sample 
databases from 2003 through 2012 
were queried for hospitalizations 
with a primary discharge diagnosis 
of ARF or ARHD using ICD-9 
codes (390, 391.x, 392.x). 
• Hospitalizations primarily for ARF 
which also had a secondary 
diagnosis of ARHD were identified 
and analyzed as a separate cohort.  
• Regression analysis was used to 
analyze outcomes. 
.  
Results 
• Hospitalizations for ARHD represented a very small 
proportion (0.002%) of the total hospitalizations in the US 
between the years 2003-2012.  
• Hospitalizations primarily or secondarily for ARHD have 
decreased by around 50% between 2003-2012 
(Ptrend<0.005). 
• Of the 11,186 hospitalizations for ARF (mean patient age 
46±28 years; 53.8% women; 50.4% white), a primary or 
secondary diagnosis of ARHD was present in 6,866 
(61.4%) (mean patient age 55±27 years; 57.4% women; 
54.2% white). ARHD in ARF patients decreased from 
63% in 2003 to 55.9% in 2012 (Ptrend< 0.005). 
• Among patients hospitalized for ARF, the likelihood of 
having ARHD is increased in female sex and white race 
(both P<0.005).  
• ARHD is more common (28%, P<0.005) in patients in the 
lowest quartile of median household income (US $ 1-
38,999).  
 
• ARHD is uncommon in the US and 
hospitalizations for ARHD have 
decreased between 2003 and 2012.  
• ARHD is common in patients with ARF 
and is associated with an increased 
length of stay, hospital charges, and in-
hospital mortality. 
• More aggressive preventive interventions 
in low-income areas might help further 
reduce the burden of this disease. 
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Among patients hospitalized for ARF, ARHD 
is an independent predictor of increased 
length of stay (8.4±9.9 vs 6.8±8.5 days in 
patients with and without ARHD, 
respectively, P<0.005), increased total 
hospital charges (US $ 62,926±107,516 vs 
46,482±88,796, P<0.005), and increased 
in-hospital mortality (4.7% vs 3% in 
patients with and without ARHD, 
respectively, P<0.005). 
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